Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corbus Pharmaceuticals Holdings (CRBP) Change in Acquisitions & Divestments (2021 - 2025)

Corbus Pharmaceuticals Holdings has reported Change in Acquisitions & Divestments over the past 3 years, most recently at $13.7 million for Q4 2023.

  • For Q4 2023, Change in Acquisitions & Divestments rose 46.18% year-over-year to $13.7 million; the TTM value through Dec 2023 reached $69.5 million, down 40.28%, while the annual FY2024 figure was $59.5 million, 14.43% down from the prior year.
  • Change in Acquisitions & Divestments for Q4 2023 was $13.7 million at Corbus Pharmaceuticals Holdings, down from $17.5 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $49.4 million in Q1 2022 and troughed at $6.9 million in Q4 2021.
  • A 3-year average of $21.4 million and a median of $17.5 million in 2023 define the central range for Change in Acquisitions & Divestments.
  • On a YoY basis, Change in Acquisitions & Divestments climbed as much as 46.18% in 2023 and fell as far as 61.86% in 2023.
  • Year by year, Change in Acquisitions & Divestments stood at $6.9 million in 2021, then surged by 36.77% to $9.4 million in 2022, then surged by 46.18% to $13.7 million in 2023.
  • Business Quant data shows Change in Acquisitions & Divestments for CRBP at $13.7 million in Q4 2023, $17.5 million in Q3 2023, and $19.4 million in Q2 2023.